CYP2D6 genotypes and depressive symptoms during late pregnancy and postpartum

Nordic Journal of Psychiatry

Volumn 58, Issue 1, 2004, Pages 61-64

  Josefsson, Ann ^a,c   Sydsjö, Gunilla ^a   Berg, Göran ^a   Dahl, Marja Liisa ^b   Wadelius, Mia ^b   Nordin, Conny ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CYP2D6; Depression; Postpartum; Pregnancy

Indexed keywords

CYTOCHROME P450 2D6; DNA;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA DETERMINATION; EUROPE; FEMALE; GENOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PUERPERIUM; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; THIRD TRIMESTER PREGNANCY;

ADULT; CYTOCHROME P-450 CYP2D6; DEPRESSION; DEPRESSION, POSTPARTUM; FEMALE; GENE DELETION; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD;

EID: 1542710209     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.1080/08039480310000815     Document Type: Article

References (30)

1. Bertilsson L, Dahl M-L. Polymorphic drug oxidation: Relevance to the treatment of psychiatric disorders. CNS Drugs 1996;5:200-23.
2. Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, et al. The dopamine transporter and cytochrome P450IID1 (Debrisoquine 4-hydroxylase) in brain: Resolution and identification of two distinct (3H) GBR-12935 binding proteins. Arch Biochem Biophysics 1990;276:424-32.
3. Tyndale RF, Sunahara R, Inaba T, Kalow W, Gonzalez FJ, Niznik HB. Neuronal cytochrome P450IID1 (debrisoquine/sparteine type) potent inhibition of activity by (-)-cocaine snd nucleotide sequence identity to human hepatic P450 gene CYP2D6. Molec Pharmacol 1991;40:63-8.
4. Kalow W, Tyndale RF. Debrisoquine/Sparteine monooxygenase and other P-450s in brain. In: Kalow W, editor. Pharmacogenetics of drug metabolism. International Encyclopedia of Pharmacology and Therapeutics. London: Pergamon Press; 1992. p. 649-56.
5. Eichelbaum M, Mineshita S, Ohnhaus EE, Zekorn C. The influence of enzyme induction on polymorphic sparteine oxidation. Br J Clin Pharmac 1986;22:49-53.
6. Dahl M-L, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjöqvist F. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J Pharmacol Exp Ther 1995;274:516-20.
7. Tamminga WJ, Wemer J, Oosterhuis B, de Zeeuw RA, de Leij LF, Jonkman JH. The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers. Eur J Clin Pharmacol 2001;57:717-22.
8. Griese EU, Zanger UM, Brudermanns U, Gaedigk A, Mikus G, Mörike K, et al. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics 1998;8:15-26.
9. Bertilsson L, Alm C, De Las Carreras C, Widen J, Edman G, Schalling D. Debrisoquine hydoxylation polymorphism and personality. Lancet 1989;ii:555.
10. Llerena. A, Edman G, Cobaleda J, Benitez J, Schalling D, Bertilsson L. Relationship between personality and debrisoquine hydroxylation capacity. Acta Psychiatr Scand 1993;87:23-8.
11. Weissman MM, Olfson M. Depression in women: Implications for health care research. Science 1995;269:799-801.
12. Llewellyn AM, Stowe ZN, Nemeroff CB. Depression during pregnancy and the puerperium. J Clin Psychiatry 1997;58(Suppl 15):26-32.
13. Josefsson A, Berg G, Nordin C, Sydsjö G. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand 2001;80:251-5.
14. Cox J, Holden J, editor. Perinatal psychiatry: Use and misuse of the Edinburgh Postpartum Depression Scale. London: Gaskell; 1994.
15. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. A population-based twin study of major depression in women. The impact of varying definitions of illness. Arch Gen Psychiatry 1992;49:257-66.
16. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996;53:391-9.
17. Treloar SA, Martin NG, Bucholz KK, Madden PAF, Heath AC. Genetic influences on post-natal depressive symptoms: Findings from an Australian twin sample. Psychol Med 1999;29:645-54.
18. Högstedt S, Lindberg B, Rane A. Increased oral clearance of metoprolol in pregnancy. Eur J Clin Pharmacol 1983;24:217-20.
19. Wadelius M, Darj E, Frenne G, Rane A. Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther 1997;62:400-7.
20. Högstedt S, Lindberg BS, Regardh CG, Mostrom U, Rane A. The Rhesus monkey as a model for studies of pregnancy-induced changes in metoprolol metabolism. Pharmacol Toxicol 1990;66:32-6.
21. Cox JL, Holden JM, Sagovsky R. Detection of postpartum depression; Development of the 10-item Edinburgh Postpartum Depression Scale. Br J Psychiatry 1987;150:782-6.
22. Lund W, Gyllang C. Use of the Edinburgh Postpartum Depression Scale in some Swedish child health care centers. Scand J Caring Sci 1993;7:149-54.
23. Bågedahl-Strindlund M, Monsen Börjesson K. Postpartum depression: A hidden illness. Acta Psychiatr Scand 1998;98:272-5.
24. Wickberg B, Hwang CR The Edinburgh Postpartum Depression Scale: Validation on a Swedish community sample. Acta Psychiatr Scand 1996;94:181-4.
25. Wolf CR, Moss JE, Miles JS, Gough AC, Spurr NK. Detection of debrisoquine hydroxylation phenotypes. Lancet 1990;336:1452-3.
26. Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE, Maraganore DM, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-7.
27. Gough A, Miles JS, Spurr NK, Moss JE, Gaedigk A, Eichelbaum M, et al. Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature 1990;347:773-6.
28. Steijns LSW, van der Weide J. Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication. Clin Chem 1998;44:914-7.
29. Mattsson P, Bjelfman C, Lundberg PO, Rane A. Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine. Eur J Clin Invest 2000;30:367-71.
30. Perrett CW, Clayton RN, Pistorello M, Boscaro M, Scanarini M, Bates AS, et al. GSTM1 and CYP2D6 genotype frequencies in patients with pitutary tumors: Effects on P53, ras and gsp. Carcinogenesis 1995;16:1643-5.